Immune cell profiling of tumor-infiltrating lymphocytes (TILs) revealed that B. bre JCM92 and B. bre Bb03 significantly increased the CD4+/Treg, CD8+/Treg, and the effector CD8+/Treg ratio (Figure 3A,B). The gene discussed is CD4; the disease is neoplasm.